SI9720011A - Ciklosporin vsebujoči mehki kapsulni pripravki - Google Patents

Ciklosporin vsebujoči mehki kapsulni pripravki Download PDF

Info

Publication number
SI9720011A
SI9720011A SI9720011A SI9720011A SI9720011A SI 9720011 A SI9720011 A SI 9720011A SI 9720011 A SI9720011 A SI 9720011A SI 9720011 A SI9720011 A SI 9720011A SI 9720011 A SI9720011 A SI 9720011A
Authority
SI
Slovenia
Prior art keywords
composition according
fatty acid
cyclosporine
ratio
weight
Prior art date
Application number
SI9720011A
Other languages
English (en)
Slovenian (sl)
Inventor
Jong Soo Woo
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019960022417A external-priority patent/KR0183449B1/ko
Priority claimed from KR1019970008750A external-priority patent/KR19980073479A/ko
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SI9720011A publication Critical patent/SI9720011A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SI9720011A 1996-06-19 1997-06-19 Ciklosporin vsebujoči mehki kapsulni pripravki SI9720011A (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1019960022417A KR0183449B1 (ko) 1996-06-19 1996-06-19 사이클로스포린-함유 연질캅셀제
KR1019970008750A KR19980073479A (ko) 1997-03-14 1997-03-14 사이클로스포린-함유 연질캅셀제
PCT/EP1997/003213 WO1997048410A1 (en) 1996-06-19 1997-06-19 Cyclosporin-containing soft capsule preparations

Publications (1)

Publication Number Publication Date
SI9720011A true SI9720011A (sl) 1998-10-31

Family

ID=26631929

Family Applications (2)

Application Number Title Priority Date Filing Date
SI9720010A SI9720010B (sl) 1996-06-19 1997-06-19 Ciklosporin vsebujoči mehki kapsulni pripravki
SI9720011A SI9720011A (sl) 1996-06-19 1997-06-19 Ciklosporin vsebujoči mehki kapsulni pripravki

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI9720010A SI9720010B (sl) 1996-06-19 1997-06-19 Ciklosporin vsebujoči mehki kapsulni pripravki

Country Status (28)

Country Link
EP (2) EP0869810B1 (de)
JP (2) JP3519414B2 (de)
KR (2) KR20000016761A (de)
CN (2) CN1494920A (de)
AT (2) ATE278412T1 (de)
AU (1) AU719251B2 (de)
BR (2) BR9706804A (de)
CA (2) CA2240705C (de)
CY (1) CY2549B1 (de)
CZ (2) CZ292378B6 (de)
DE (2) DE69731072T2 (de)
DK (1) DK0869810T3 (de)
ES (2) ES2305396T3 (de)
HK (1) HK1010492A1 (de)
HU (1) HUP9801109A3 (de)
IL (5) IL123840A (de)
MX (2) MX9804414A (de)
MY (1) MY117765A (de)
NO (2) NO321921B1 (de)
NZ (1) NZ330062A (de)
PL (1) PL188500B1 (de)
PT (2) PT869810E (de)
RU (2) RU2181055C2 (de)
SG (1) SG88752A1 (de)
SI (2) SI9720010B (de)
SK (2) SK283216B6 (de)
TR (2) TR199800525T2 (de)
WO (1) WO1997048410A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980073479A (ko) * 1997-03-14 1998-11-05 한스루돌프하우스, 니콜케르커 사이클로스포린-함유 연질캅셀제
AU722285B2 (en) * 1996-06-19 2000-07-27 Novartis Ag Cyclosporin-containing soft capsule preparations
ATE278412T1 (de) * 1996-06-19 2004-10-15 Novartis Pharma Gmbh Cyclosporin enthaltende weichkapselpräparate
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
NZ329929A (en) * 1998-03-09 1999-10-28 Bernard Charles Sherman Pharmaceutical emulsion preconcentrate containing cyclosporin in a solvent system containing glycerides, propylene or polyethylene glycol, a surfactant and a co-surfactant
SI1333851T1 (sl) 2000-09-18 2008-02-29 Rpg Life Sciences Ltd Sestavek, ki sam po sebi tvori emulzijo, z izboljsanimi bioabsobcijskimi in imunosupresijskimi aktivnostmi
CZ20033341A3 (cs) 2001-06-21 2004-10-13 Pfizeráproductsáinc Samoemulgující se kompozice inhibitorů přenosového proteinu cholesterylesteru
FR2838349B1 (fr) * 2002-04-15 2004-06-25 Laurence Paris Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication
KR100533460B1 (ko) * 2002-07-20 2005-12-08 대화제약 주식회사 난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법
US20070092559A1 (en) * 2005-10-24 2007-04-26 Jinghua Yuan Liquid dosage forms having enteric properties of delayed and then sustained release
FR3029792B1 (fr) * 2014-12-15 2018-01-26 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Liberation maitrisee de substances actives.
KR20170001569U (ko) 2015-10-27 2017-05-10 이제홍 쑥뜸장치

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2038969A1 (en) * 1990-03-30 1991-10-01 Michel J. N. Cormier Compositions comprising cytotoxic agent and permeation enhancers
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
KR0167613B1 (ko) * 1994-12-28 1999-01-15 한스 루돌프 하우스, 니콜 케르커 사이클로스포린-함유 연질캅셀제 조성물
NZ280689A (en) * 1995-12-15 1997-08-22 Bernard Charles Sherma Sherman Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
ATE278412T1 (de) * 1996-06-19 2004-10-15 Novartis Pharma Gmbh Cyclosporin enthaltende weichkapselpräparate

Also Published As

Publication number Publication date
HUP9801109A2 (hu) 1999-08-30
DK0869810T3 (da) 2005-02-07
IL123840A0 (en) 1998-10-30
SK283216B6 (sk) 2003-03-04
CA2226091A1 (en) 1997-12-24
PT869810E (pt) 2005-01-31
ES2227700T3 (es) 2005-04-01
ATE392891T1 (de) 2008-05-15
CA2240705A1 (en) 1997-12-24
DE69738656D1 (de) 2008-06-05
CA2240705C (en) 2007-07-31
CN1127350C (zh) 2003-11-12
TR199800526T2 (xx) 1999-02-22
RU2185187C2 (ru) 2002-07-20
BR9706804A (pt) 1999-11-03
NO981200D0 (no) 1998-03-17
NZ330062A (en) 2000-01-28
EP1413297A1 (de) 2004-04-28
ATE278412T1 (de) 2004-10-15
NO982382L (no) 1998-05-26
AU3341197A (en) 1998-01-07
NO982382D0 (no) 1998-05-26
CA2226091C (en) 1999-02-09
SG88752A1 (en) 2002-05-21
KR20040000379A (ko) 2004-01-03
IL123676A (en) 2002-02-10
JP2000505480A (ja) 2000-05-09
CZ292378B6 (cs) 2003-09-17
EP1413297B1 (de) 2008-04-23
PT1413297E (pt) 2008-07-28
TR199800525T2 (xx) 1999-02-22
EP0869810A1 (de) 1998-10-14
IL123676A0 (en) 1998-10-30
IL123840A (en) 2002-07-25
CY2549B1 (en) 2008-07-02
IL147369A0 (en) 2002-08-14
MY117765A (en) 2004-08-30
DE69738656T2 (de) 2009-06-04
JP3519414B2 (ja) 2004-04-12
HK1010492A1 (en) 1999-06-25
WO1997048410A1 (en) 1997-12-24
AU719251B2 (en) 2000-05-04
SK37198A3 (en) 1998-10-07
DE69731072D1 (de) 2004-11-11
SI9720010B (sl) 2009-10-31
CZ83498A3 (cs) 1998-07-15
KR20000016761A (ko) 2000-03-25
NO321921B1 (no) 2006-07-24
CZ83598A3 (cs) 1998-07-15
PL325832A1 (en) 1999-01-04
IL147369A (en) 2002-12-01
PL188500B1 (pl) 2005-02-28
DE69731072T2 (de) 2005-10-06
SK283361B6 (sk) 2003-06-03
BR9713811A (pt) 2004-03-02
RU2181055C2 (ru) 2002-04-10
CN1207044A (zh) 1999-02-03
NO981200L (no) 1998-03-17
CZ291641B6 (cs) 2003-04-16
MX9804442A (es) 1998-09-30
SI9720010A (sl) 1998-10-31
SK37298A3 (en) 1998-10-07
JP2004043511A (ja) 2004-02-12
NO323816B1 (no) 2007-07-09
MX9804414A (es) 1998-09-30
EP0869810B1 (de) 2004-10-06
ES2305396T3 (es) 2008-11-01
HUP9801109A3 (en) 2000-06-28
CN1494920A (zh) 2004-05-12

Similar Documents

Publication Publication Date Title
US5589455A (en) Cyclosporin-containing soft capsule compositions
US5603951A (en) Cyclosporin-containing soft capsule compositions
US5958876A (en) Cyclosporin-containing pharmaceutical compositions
EP0813876B1 (de) Cyclosporin enthaltende Weichkapselpräparate
SI9720011A (sl) Ciklosporin vsebujoči mehki kapsulni pripravki
RU2185188C2 (ru) Фармацевтические композиции
AU753018B2 (en) Cyclosporin-containing soft capsule preparations
AU722285B2 (en) Cyclosporin-containing soft capsule preparations
MXPA99008438A (en) Pharmaceutical compositions
KR100464617B1 (ko) 사이클로스포린-함유연질캅셀제
AU1944200A (en) Cyclosporin-containing soft capsule preparations
KR20060086489A (ko) 사이클로스포린-함유 연질캅셀제

Legal Events

Date Code Title Description
IF Valid on the event date
OU01 Decison according to article 73(1) ipa 1992, publication of decision on fulfilment of conditions on patentability

Effective date: 20060517

KO00 Lapse of patent

Effective date: 20110124